If you're considering LATISSE^® (bimatoprost ophthalmic solution) 0.03%, it's important to get all the facts. You may have questions about how the treatment works, how soon you'll see results and, of course, the safety of the product. This site was intended to give you a basic understanding of the product, but you should talk to your doctor to see if LATISSE^® is right for you.

The first step: talk to your doctor

While any doctor can prescribe LATISSE^®, we encourage you to use our Find a Doctor tool to help you locate a doctor who may be more likely to know about this FDA-approved treatment. Your doctor will evaluate your medical history to determine if you're a good candidate for LATISSE^®. If you have an eye infection, broken or irritated upper eyelid skin, or if you are using products for elevated intraocular pressure, talk to your doctor.

What are the side effects?

The most common side effects after using LATISSE^® solution are an itching sensation in the eyes and/or eye redness, which were reported in approximately 4% of patients. These may occur immediately after use, but should usually last only for a short period of time. Eye itching and eye redness are not allergic reactions, and do not mean that your eyes are being harmed.

LATISSE^® solution may cause other less common side effects, which typically occur on the skin close to where LATISSE^® is applied, or in the eyes. These include eye irritation, dryness of the eyes, and redness of the eyelids. Skin darkening (or hyperpigmentation) is another less common side effect. This condition causes areas of skin to become darker than the surrounding skin color, but has been reported to be reversible after discontinuation of the product.

You should always only use the FDA-approved sterile applicators to apply LATISSE^® directly to the base of your upper eyelashes. The applicators have been specially designed and manufactured to meet FDA standards, and help patients properly apply the product.

Could LATISSE^® cause the color of my eyes to change?

Increased brown iris pigmentation has occurred when similar medications were instilled directly into the eye to treat elevated intraocular pressure/glaucoma. Although iris pigmentation was not reported in clinical studies with LATISSE^®, patients should be advised about the potential for increased brown iris pigmentation which is likely to be permanent.

Is LATISSE^® safe?

LATISSE^® is an FDA-approved prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker and darker. Hypotrichosis is another name for having inadequate or not enough eyelashes. The FDA reviewed clinical study results to verify the identity, potency, purity and stability of the ingredients, and demonstrated that the product is safe and effective for its intended use if used as prescribed.